{"nct_id":"NCT01922102","title":"Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia","status":"COMPLETED","status_verified_date":"2019-03","start_date":"2013-09-11","start_date_type":"ACTUAL","primary_completion_date":"2016-09-14","primary_completion_date_type":"ACTUAL","completion_date":"2016-09-14","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}